美股A股
StockGist
Back
6-K2026-05-13· deepseek-chat

TAK · Takeda Pharmaceutical Company Limited

0001395064-26-000147

SEC filing

Summary

Takeda continues its stock compensation plan for directors and stock grant system for management in Japan for 2026, extending trust terms and entrusting additional funds.

Key takeaways